Profound Medical (PROF) Income from Continuing Operations (2024 - 2026)
Profound Medical (PROF) recorded quarterly Income from Continuing Operations of 7055000.0 in Q1 2026, up 13.55% quarter-over-quarter from 8161000.0 in Q4 2025, and up 34.21% on a YoY basis from 5256570.56 in Q1 2025.
Profound Medical (PROF) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Profound Medical's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 7055000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 34.21% year-over-year to 7055000.0; the TTM figure through Mar 2026 stood at 38902000.0 (down 919.71% YoY), while the FY2025 annual figure was 42549000.0, down 13232.41% from the prior year.
- Income from Continuing Operations was 7055000.0 for Q1 2026 at Profound Medical, up from 8161000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 23193000.0 in Q4 2024 to a low of 15709000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 5478000.0 across 3 years, with a median of 7977000.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations plunged 135.19% in 2025, then soared 34.21% in 2026.
- A 3-year view of Income from Continuing Operations shows it stood at 23193000.0 in 2024, then tumbled by 135.19% to 8161000.0 in 2025, then increased by 13.55% to 7055000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 7055000.0 (Q1 2026), 8161000.0 (Q4 2025), and 7977000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Profound Medical | 246.10 Mn | 195.80 Mn | 3.83 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -8.16 Mn |
| Sep 30, 2025 | -7.98 Mn |
| Jun 30, 2025 | -15.71 Mn |
| Mar 31, 2025 | -10.72 Mn |
| Dec 31, 2024 | 23.19 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -6.92 Mn |
| Mar 31, 2024 | -6.59 Mn |